CSC-Driven Angiogenesis

Angiogenesis, the formation of new blood vessels, is essential for tumor growth and metastasis. Cancer stem cells (CSCs) play a key role in promoting angiogenesis by secreting pro-angiogenic factors like VEGF. This track investigates how CSCs drive the formation of new vasculature to support their growth and survival in the tumor microenvironment. Researchers explore therapeutic strategies that inhibit CSC-induced angiogenesis, potentially starving tumors of the blood supply they need to grow and spread. Targeting CSCs' role in angiogenesis could lead to more effective anti-angiogenic therapies that not only shrink tumors but also prevent their recurrence and metastasis.

    Related Conference of CSC-Driven Angiogenesis

    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    November 28-29, 2024

    14th World Congress on Breast Cancer

    Paris, France
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    December 12-13, 2024

    44th Euro Congress on Cancer Science & Therapy

    Rome, Italy
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands

    CSC-Driven Angiogenesis Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in